Gen AI Present and Future: A Conversation with Bijoy Sagar, Global CIO and Digital Transformation Officer of Bayer

Bayer's Global CIO discusses how the company is deploying Gen AI across drug discovery, clinical trials, crop science, and internal operations—emphasizing that business problems should drive AI adoption, not hype. He predicts LLM commoditization, the rise of specialized models, tighter AI regulation, and data access limits.

Read the full post on Greylock News ↗

Topics: AI (Horizontal) · Biotech & Life Sciences · Food & Agriculture

Published by Greylock News · their site ↗

SandHill indexes 800+ venture capital blogs and newsletters and sends the best of them every Sunday. Browse the sources · browse by topic · read the blog.